Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
March 4, 2025
Exposotypes in Psychotic Disorders
Walid Yassin, Bryan Kromenacker, James B Green, et al.
Scientific Reports
|
August 8, 2025
Exposotypes in psychotic disorders
Walid Yassin, Bryan Kromenacker, James B Green, et al.
Schizophrenia Research
|
March 29, 2023
Characterization of childhood trauma, hippocampal mediation and Cannabis use in a large dataset of psychosis and non-psychosis individuals
Elisabetta C Del Re, Walid Yassin, Victor Zeng, et al.
Molecular Psychiatry
|
June 30, 2018
Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial
Hidenori Yamasue, Takashi Okada, Toshio Munesue, et al.
Brain : a Journal of Neurology
|
May 17, 2019
Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism
Keiho Owada, Takashi Okada, Toshio Munesue, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 27, 2026
Cognition and Electrophysiology Clustering in Clinical High Risk for Psychosis Delineates Distinct Dimensions of Heterogeneity: Implications for Multimodal Clustering
Walid Yassin, James B Green, Michael Cai, et al.
Molecular Psychiatry
|
March 28, 2026
A key gene modulating oxytocin efficacy in autism: genome-wide discovery and verification in randomized controlled trials datasets
Hitoshi Kuwabara, Masaki Kojima, Seico Benner, et al.
Cell Reports
|
September 13, 2018
Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights
Itaru Kushima, Branko Aleksic, Masahiro Nakatochi, et al.
Schizophrenia (Heidelberg, Germany)
|
October 15, 2025
Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative
Zarina R Bilgrami, Eduardo Castro, Carla Agurto, et al.
Schizophrenia Bulletin
|
May 11, 2026
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-Schizophrenia
Henry R Cowan, Danielle Pratt, Jai L Shah, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Medrxiv : the Preprint Server for Health Sciences
|
March 4, 2025
Exposotypes in Psychotic Disorders
Walid Yassin, Bryan Kromenacker, James B Green, et al.
Scientific Reports
|
August 8, 2025
Exposotypes in psychotic disorders
Walid Yassin, Bryan Kromenacker, James B Green, et al.
Schizophrenia Research
|
March 29, 2023
Characterization of childhood trauma, hippocampal mediation and Cannabis use in a large dataset of psychosis and non-psychosis individuals
Elisabetta C Del Re, Walid Yassin, Victor Zeng, et al.
Molecular Psychiatry
|
June 30, 2018
Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial
Hidenori Yamasue, Takashi Okada, Toshio Munesue, et al.
Brain : a Journal of Neurology
|
May 17, 2019
Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism
Keiho Owada, Takashi Okada, Toshio Munesue, et al.
Medrxiv : the Preprint Server for Health Sciences
|
March 27, 2026
Cognition and Electrophysiology Clustering in Clinical High Risk for Psychosis Delineates Distinct Dimensions of Heterogeneity: Implications for Multimodal Clustering
Walid Yassin, James B Green, Michael Cai, et al.
Molecular Psychiatry
|
March 28, 2026
A key gene modulating oxytocin efficacy in autism: genome-wide discovery and verification in randomized controlled trials datasets
Hitoshi Kuwabara, Masaki Kojima, Seico Benner, et al.
Cell Reports
|
September 13, 2018
Comparative Analyses of Copy-Number Variation in Autism Spectrum Disorder and Schizophrenia Reveal Etiological Overlap and Biological Insights
Itaru Kushima, Branko Aleksic, Masahiro Nakatochi, et al.
Schizophrenia (Heidelberg, Germany)
|
October 15, 2025
Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative
Zarina R Bilgrami, Eduardo Castro, Carla Agurto, et al.
Schizophrenia Bulletin
|
May 11, 2026
Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-Schizophrenia
Henry R Cowan, Danielle Pratt, Jai L Shah, et al.
Page
of 5